Vergleich

Small Molecules

550512 Artikel

pro Seite

Seite:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge Preis
RSV-­604 Inhibitors Other DCC-DC10006-10mM

DCChemicals
10 mM x 1 ml in DMSO Anmelden
Vergleichen
Ibiglustat(Genz-­682452) Inhibitors Other DCC-DC10007-10mM

DCChemicals
10 mM x 1 ml in DMSO Anmelden
Vergleichen
FK-­506 (Tacrolimus) Inhibitors Other DCC-DC1001-10mM

DCChemicals
10 mM x 1 ml in DMSO Anmelden
Vergleichen
MRTX-­1719 Inhibitors Other DCC-DC47117-100mg

DCChemicals
100 mg Anmelden
Vergleichen
11R-­VIVIT Inhibitors Other 11R-VIVIT is a potent NFAT inhibitor. 11R-VIVIT inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). 11R-VIVIT also attenuates NO production and Nos2 mRNA expression in LPS-stimulated BMDMs. 11R-VIVIT improves symptoms in a mouse model of colitis. Exhibits immunosuppressive effects; en DCC-DC45087-10mg

DCChemicals
10 mg Anmelden
Vergleichen
RP101988 Chemicals Other DCC-DC46471-100mg

DCChemicals
100 mg Anmelden
Vergleichen
CDC 5-­LO inhibitor Inhibitors Other DCC-DC44939-250mg

DCChemicals
250 mg Anmelden
Vergleichen
GPR40/­FFAR1 modulator 1(WUN55267) Inhibitors Other DCC-DC46241-1g

DCChemicals
1 g Anmelden
Vergleichen
Emraclidine Inhibitors Other DCC-DC46844-100mg

DCChemicals
100 mg Anmelden
Vergleichen
Emraclidine Inhibitors Other DCC-DC46844-250mg

DCChemicals
250 mg Anmelden
Vergleichen
Thailanstatin A Inhibitors Other other DCC-DC45695-10mg

DCChemicals
10 mg Anmelden
Vergleichen
Vodobatinib Inhibitors Other Vodobatinib (K0706) is a potent, third generation and orally active Bcr-Abl1 tyrosine kinase inhibitor with an IC50 of 7 nM. Vodobatinib exhibits activity against most BCR-ABL1 point mutants, and has no activity against BCR-ABL1T315I. Vodobatinib can be used for chronic myeloid leukemia (CML) research. DCC-DC44827-100mg

DCChemicals
100 mg Anmelden
Vergleichen
Vodobatinib Inhibitors Other Vodobatinib (K0706) is a potent, third generation and orally active Bcr-Abl1 tyrosine kinase inhibitor with an IC50 of 7 nM. Vodobatinib exhibits activity against most BCR-ABL1 point mutants, and has no activity against BCR-ABL1T315I. Vodobatinib can be used for chronic myeloid leukemia (CML) research. DCC-DC44827-250mg

DCChemicals
250 mg Anmelden
Vergleichen
Iclepertin Inhibitors Other DCC-DC46952-250mg

DCChemicals
250 mg Anmelden
Vergleichen
Iclepertin Inhibitors Other DCC-DC46952-1g

DCChemicals
1 g Anmelden
Vergleichen
2'-­Deoxyuridine 5'-­monophosphate disodium Inhibitors Other DCC-DC45589-250mg

DCChemicals
250 mg Anmelden
Vergleichen
DTHIB Inhibitors Other DTHIB is a direct and selective heat shock factor 1 (HSF1) inhibitor with a Kd of 160 nM for DTHIB binding to the HSF1 DNA binding domain (DBD). DTHIB inhibits HSF1 cancer gene signature (HSF1 CaSig) and selectively stimulates degradation of nuclear HSF1. DCC-DC44513-100mg

DCChemicals
100 mg Anmelden
Vergleichen
Disodium 5'-­dGMP Inhibitors Other DCC-DC45590-250mg

DCChemicals
250 mg Anmelden
Vergleichen
Disodium 5'-­dGMP Inhibitors Other DCC-DC45590-1g

DCChemicals
1 g Anmelden
Vergleichen
Enasidenib Mesylate Inhibitors Other DCC-DC44726-250mg

DCChemicals
250 mg Anmelden
Vergleichen
Enasidenib Mesylate Inhibitors Other DCC-DC44726-1g

DCChemicals
1 g Anmelden
Vergleichen
Lipase Substrate Inhibitors Other DCC-DC45418-100mg

DCChemicals
100 mg Anmelden
Vergleichen
Ziftomenib Inhibitors Other DCC-DC46835-5mg

DCChemicals
5 mg Anmelden
Vergleichen
Etavopivat Inhibitors Other DCC-DC47090-5mg

DCChemicals
5 mg Anmelden
Vergleichen
Dalpiciclib Inhibitors Other DCC-DC46943-100mg

DCChemicals
100 mg Anmelden
Vergleichen
Name Preis
RSV-­604 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 10 mM x 1 ml in DMSO
Lieferbar
Ibiglustat(Genz-­682452) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 10 mM x 1 ml in DMSO
Lieferbar
FK-­506 (Tacrolimus) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 10 mM x 1 ml in DMSO
Lieferbar
MRTX-­1719 Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
11R-­VIVIT Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. 11R-VIVIT is a potent NFAT inhibitor. 11R-VIVIT inhibits LPS or LPS plus IFN-γ-induced IL-12 p40, IL-12 p70, IL-23 and TNF secretion from bone marrow-derived macrophages (BMDMs). 11R-VIVIT also attenuates NO production and Nos2 mRNA expression in LPS-stimulated BMDMs. 11R-VIVIT improves symptoms in a mouse model of colitis. Exhibits immunosuppressive effects; en
Host
ArtNr.
Menge 10 mg
Lieferbar
RP101988 Anmelden
Typ Chemicals
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
CDC 5-­LO inhibitor Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
GPR40/­FFAR1 modulator 1(WUN55267) Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 1 g
Lieferbar
Emraclidine Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Emraclidine Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
Thailanstatin A Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. other
Host
ArtNr.
Menge 10 mg
Lieferbar
Vodobatinib Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. Vodobatinib (K0706) is a potent, third generation and orally active Bcr-Abl1 tyrosine kinase inhibitor with an IC50 of 7 nM. Vodobatinib exhibits activity against most BCR-ABL1 point mutants, and has no activity against BCR-ABL1T315I. Vodobatinib can be used for chronic myeloid leukemia (CML) research.
Host
ArtNr.
Menge 100 mg
Lieferbar
Vodobatinib Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. Vodobatinib (K0706) is a potent, third generation and orally active Bcr-Abl1 tyrosine kinase inhibitor with an IC50 of 7 nM. Vodobatinib exhibits activity against most BCR-ABL1 point mutants, and has no activity against BCR-ABL1T315I. Vodobatinib can be used for chronic myeloid leukemia (CML) research.
Host
ArtNr.
Menge 250 mg
Lieferbar
Iclepertin Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
Iclepertin Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 1 g
Lieferbar
2'-­Deoxyuridine 5'-­monophosphate disodium Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
DTHIB Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl. DTHIB is a direct and selective heat shock factor 1 (HSF1) inhibitor with a Kd of 160 nM for DTHIB binding to the HSF1 DNA binding domain (DBD). DTHIB inhibits HSF1 cancer gene signature (HSF1 CaSig) and selectively stimulates degradation of nuclear HSF1.
Host
ArtNr.
Menge 100 mg
Lieferbar
Disodium 5'-­dGMP Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
Disodium 5'-­dGMP Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 1 g
Lieferbar
Enasidenib Mesylate Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 250 mg
Lieferbar
Enasidenib Mesylate Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 1 g
Lieferbar
Lipase Substrate Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Ziftomenib Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 5 mg
Lieferbar
Etavopivat Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 5 mg
Lieferbar
Dalpiciclib Anmelden
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar

550512 Artikel

pro Seite

Seite:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5